Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2003
June 1, 2003
- Focus on Arthritis
- Study: Oxaliplatin significantly decreases the risk of relapse after surgery from colorectal cancer
June 2, 2003
June 3, 2003
June 5, 2003
June 12, 2003
June 13, 2003
- FDA approves Stalevo for treatment of Parkinson's Disease -- reduces signs and symptoms
- FDA issues generic drug final rules
June 16, 2003
June 17, 2003
- Promising results shorten UK Lipitor trial in type 2 diabetes patients by two years
- British Columbia approval of Pegetron for hepatitis C completes Canada-wide coverage
- FDA approves needle-free FluMist -- first flu vaccine delivery innovation in over 50 years
- Stanford research finds better results in newer antipsychotic medicines
- Study shows type-2 diabetes drug rosiglitazone may limit heart disease risk
- PhRMA tells senators patent incentives for discovery of new medicines must be maintained
- Investigational new drug status cleared by FDA for phenoxodiol in oral form
- Yale study shows lofexidine is effective in preventing opiate addiction relapse
- Curacyte scientists discover new anti-tumor agents
- drugstore.com. reaches 2 million prescriptions as savings and convenience drive acceptance
- ASHP Policy Positions: Causes of and solutions to drug product shortages
June 25, 2003
- FDA approves first co-packaged treatments to reduce occurrence of serious cardiovascular and cerebrovascular events
- CBER warns Allergan again about Botox ads
June 26, 2003
- House Committee probes Medicaid fraud, contacts 26 drug companies, 3 wholesalers
- Pfizer experimental compounds being investigated for utility in malaria, SARS, smallpox
- Fast-track designation for Avastin in first-line metastatic colorectal cancer treatment
June 27, 2003
June 30, 2003
- Corixa and GlaxoSmithKline announce FDA approval of Bexxar
- Blue Cross and Blue Shield Plans act in response to 'pharmaceutical industry promo tactics'
- Law firm to file suit on behalf of victims of Accutane side effects
- FDA accepts for review new drug application for trospium
- Protecting public health: FDA pursues an aggressive enforcement strategy
